GSA Capital Partners LLP bought a new position in Docusign Inc. (NASDAQ:DOCU – Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 29,315 shares of the company’s stock, valued at approximately $1,302,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC increased its holdings in shares of Docusign by 8.2% in the second quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock valued at $166,000 after purchasing an additional 165 shares during the period. Centaurus Financial Inc. lifted its holdings in shares of Docusign by 3.4% during the third quarter. Centaurus Financial Inc. now owns 5,582 shares of the company’s stock worth $402,000 after purchasing an additional 184 shares during the period. Tred Avon Family Wealth LLC boosted its position in Docusign by 3.6% in the first quarter. Tred Avon Family Wealth LLC now owns 6,176 shares of the company’s stock valued at $293,000 after buying an additional 215 shares during the last quarter. Sanctuary Advisors LLC increased its holdings in Docusign by 2.4% in the 4th quarter. Sanctuary Advisors LLC now owns 9,685 shares of the company’s stock worth $662,000 after buying an additional 231 shares during the period. Finally, First Citizens Bank & Trust Co. raised its position in Docusign by 2.1% during the 1st quarter. First Citizens Bank & Trust Co. now owns 11,745 shares of the company’s stock worth $557,000 after buying an additional 239 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
Docusign Stock Down 3.6%
Shares of NASDAQ DOCU opened at $59.82 on Tuesday. The firm has a market cap of $11.42 billion, a price-to-earnings ratio of 38.84, a price-to-earnings-growth ratio of 1.83 and a beta of 0.87. The company’s 50-day simple moving average is $50.26 and its 200-day simple moving average is $48.39. Docusign Inc. has a 52-week low of $40.16 and a 52-week high of $86.65.
Analysts Set New Price Targets
Several analysts have commented on the stock. Jefferies Financial Group lifted their price objective on shares of Docusign from $45.00 to $50.00 and gave the company a “hold” rating in a research note on Friday, June 5th. Wedbush reduced their target price on shares of Docusign from $60.00 to $58.00 and set a “neutral” rating for the company in a report on Friday, June 5th. BTIG Research decreased their target price on shares of Docusign from $70.00 to $60.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Citigroup upped their price target on shares of Docusign from $50.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, June 5th. Finally, Weiss Ratings raised Docusign from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, July 14th. Three research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Docusign has an average rating of “Hold” and an average target price of $60.27.
Read Our Latest Stock Report on DOCU
Insider Activity at Docusign
In other news, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $546,480.00. Following the completion of the sale, the insider owned 52,815 shares of the company’s stock, valued at $2,405,195.10. This represents a 18.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robert Chatwani sold 15,902 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $43.01, for a total transaction of $683,945.02. Following the sale, the insider owned 72,805 shares of the company’s stock, valued at $3,131,343.05. This represents a 17.93% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 91,695 shares of company stock valued at $4,376,002 over the last ninety days. Corporate insiders own 0.59% of the company’s stock.
Docusign Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Featured Stories
- Five stocks we like better than Docusign
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
